Molecular markers in head and neck squamous cell carcinoma: Their biological function and prognostic significance

B. D. Smith, Bruce Haffty, C. T. Sasaki

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Head and neck squamous cell carcinoma affects more than 500,000 people worldwide each year. Despite optimal treatment with surgery, irradiation, and chemotherapy, disease recurrence and progression remains a common and challenging oncological problem. Recently, interest has developed in identifying novel molecular markers that allow identification of those patients at increased risk for locoregional recurrence and death. This article reviews several such molecular markers studied in head and neck cancer, including p53, angiogenesis-related markers, cyclin D1, and epidermal growth factor receptor. The biological function of these markers and the potential clinical implications are discussed. The purpose of this review is to update the otolaryngologist on a rapidly emerging segment of applied translational research in our field.

Original languageEnglish (US)
Pages (from-to)221-228
Number of pages8
JournalAnnals of Otology, Rhinology and Laryngology
Volume110
Issue number3
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

Recurrence
Translational Medical Research
Cyclin D1
Head and Neck Neoplasms
Epidermal Growth Factor Receptor
Disease Progression
Biomarkers
Drug Therapy
Carcinoma, squamous cell of head and neck
Therapeutics
Otolaryngologists

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

@article{51a0150420824d1cb8c9c4f1716b6986,
title = "Molecular markers in head and neck squamous cell carcinoma: Their biological function and prognostic significance",
abstract = "Head and neck squamous cell carcinoma affects more than 500,000 people worldwide each year. Despite optimal treatment with surgery, irradiation, and chemotherapy, disease recurrence and progression remains a common and challenging oncological problem. Recently, interest has developed in identifying novel molecular markers that allow identification of those patients at increased risk for locoregional recurrence and death. This article reviews several such molecular markers studied in head and neck cancer, including p53, angiogenesis-related markers, cyclin D1, and epidermal growth factor receptor. The biological function of these markers and the potential clinical implications are discussed. The purpose of this review is to update the otolaryngologist on a rapidly emerging segment of applied translational research in our field.",
author = "Smith, {B. D.} and Bruce Haffty and Sasaki, {C. T.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1177/000348940111000304",
language = "English (US)",
volume = "110",
pages = "221--228",
journal = "Annals of Otology, Rhinology and Laryngology",
issn = "0003-4894",
publisher = "Annals Publishing Company",
number = "3",

}

Molecular markers in head and neck squamous cell carcinoma : Their biological function and prognostic significance. / Smith, B. D.; Haffty, Bruce; Sasaki, C. T.

In: Annals of Otology, Rhinology and Laryngology, Vol. 110, No. 3, 01.01.2001, p. 221-228.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Molecular markers in head and neck squamous cell carcinoma

T2 - Their biological function and prognostic significance

AU - Smith, B. D.

AU - Haffty, Bruce

AU - Sasaki, C. T.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Head and neck squamous cell carcinoma affects more than 500,000 people worldwide each year. Despite optimal treatment with surgery, irradiation, and chemotherapy, disease recurrence and progression remains a common and challenging oncological problem. Recently, interest has developed in identifying novel molecular markers that allow identification of those patients at increased risk for locoregional recurrence and death. This article reviews several such molecular markers studied in head and neck cancer, including p53, angiogenesis-related markers, cyclin D1, and epidermal growth factor receptor. The biological function of these markers and the potential clinical implications are discussed. The purpose of this review is to update the otolaryngologist on a rapidly emerging segment of applied translational research in our field.

AB - Head and neck squamous cell carcinoma affects more than 500,000 people worldwide each year. Despite optimal treatment with surgery, irradiation, and chemotherapy, disease recurrence and progression remains a common and challenging oncological problem. Recently, interest has developed in identifying novel molecular markers that allow identification of those patients at increased risk for locoregional recurrence and death. This article reviews several such molecular markers studied in head and neck cancer, including p53, angiogenesis-related markers, cyclin D1, and epidermal growth factor receptor. The biological function of these markers and the potential clinical implications are discussed. The purpose of this review is to update the otolaryngologist on a rapidly emerging segment of applied translational research in our field.

UR - http://www.scopus.com/inward/record.url?scp=0035104374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035104374&partnerID=8YFLogxK

U2 - 10.1177/000348940111000304

DO - 10.1177/000348940111000304

M3 - Article

C2 - 11269765

AN - SCOPUS:0035104374

VL - 110

SP - 221

EP - 228

JO - Annals of Otology, Rhinology and Laryngology

JF - Annals of Otology, Rhinology and Laryngology

SN - 0003-4894

IS - 3

ER -